Adial Pharmaceuticals Delays Shareholder Meeting to Oct. 26 Pending Nasdaq Approval
Adial Pharmaceuticals further adjourned its 2026 annual shareholder meeting to October 26 at 8:30 a.m. Eastern Time, pending Nasdaq listing approval. Voting remains open on four proposals postponed again on October 15; the meeting will reconvene at its Charlottesville, Virginia, offices. The August 17 record date remai